Cargando…

Breast and pancreatic cancer interrupt IRF8-dependent dendritic cell development to overcome immune surveillance

Tumors employ multiple mechanisms to evade immune surveillance. One mechanism is tumor-induced myelopoiesis, whereby the expansion of immunosuppressive myeloid cells can impair tumor immunity. As myeloid cells and conventional dendritic cells (cDCs) are derived from the same progenitors, we postulat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meyer, Melissa A., Baer, John M., Knolhoff, Brett L., Nywening, Timothy M., Panni, Roheena Z., Su, Xinming, Weilbaecher, Katherine N., Hawkins, William G., Ma, Cynthia, Fields, Ryan C., Linehan, David C., Challen, Grant A., Faccio, Roberta, Aft, Rebecca L., DeNardo, David G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871846/ https://www.ncbi.nlm.nih.gov/pubmed/29593283 http://dx.doi.org/10.1038/s41467-018-03600-6

Ejemplares similares

Tumor-infiltrating macrophages, cancer stem cells and therapeutic responses
por: Panni, Roheena Z., et al.
Publicado: (2012)

Targeting both tumour-associated CXCR2(+) neutrophils and CCR2(+) macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma
por: Nywening, Timothy M, et al.
Publicado: (2018)

SNAIL1 action in tumor cells influences macrophage polarization and metastasis in breast cancer through altered GM-CSF secretion
por: Brenot, Audrey, et al.
Publicado: (2018)

Targeting Focal Adhesion Kinase Renders Pancreatic Cancers Responsive to Checkpoint Immunotherapy
por: Jiang, Hong, et al.
Publicado: (2016)

Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer
por: Panni, Roheena Z., et al.
Publicado: (2014)

Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic
por: Ohman, Kerri A., et al.
Publicado: (2016)

Targeting focal adhesion kinase reprograms the pancreatic tumor microenvironment and renders pancreas cancer responsive to checkpoint immunotherapy
por: Jiang, Hong, et al.
Publicado: (2015)

Dickkopf-related protein 1 (Dkk1) regulates the accumulation and function of myeloid derived suppressor cells in cancer
por: D’Amico, Lucia, et al.
Publicado: (2016)

Earlier surgical intervention in congenital heart disease results in better outcome and resource utilization
por: Panni, Roheena Z, et al.
Publicado: (2011)

Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer
por: Aft, R L, et al.
Publicado: (2012)

Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis
por: Ruhland, Megan K., et al.
Publicado: (2016)

Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy
por: Zuo, Chong, et al.
Publicado: (2023)

Interrupting Neuron—Tumor Interactions to Overcome Treatment Resistance
por: Hunt, Patrick J., et al.
Publicado: (2020)

Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression
por: DeNardo, David G, et al.
Publicado: (2007)

Battle over CCL2 for control of the metastatic niche: neutrophils versus monocytes
por: Mitchem, Jonathan B, et al.
Publicado: (2012)

I-fibrinogen as an oncophilic radiodiagnostic agent: distribution kinetics in tumour-bearing mice.
por: Krohn, K. A., et al.
Publicado: (1977)

Induction of cancer neoantigens facilitates development of clinically relevant models for the study of pancreatic cancer immunobiology
por: Panni, Usman Y., et al.
Publicado: (2023)

A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-type glioblastoma
por: Ghosh, Subhajit, et al.
Publicado: (2023)

Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity
por: DeNardo, David G., et al.
Publicado: (2010)

Rethinking immune checkpoint blockade: ‘Beyond the T cell’
por: Liu, Xiuting, et al.
Publicado: (2021)

Sustainable Developmental Goals interrupted: Overcoming challenges to global child and adolescent health
por: Bhutta, Zulfiqar A., et al.
Publicado: (2021)

The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer
por: Schwartz, J. L., et al.
Publicado: (2011)

DNA-binding landscape of IRF3, IRF5 and IRF7 dimers: implications for dimer-specific gene regulation
por: Andrilenas, Kellen K, et al.
Publicado: (2018)

IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling
por: Lazear, Helen M., et al.
Publicado: (2013)

Correction: IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling
por: Lazear, Helen M., et al.
Publicado: (2013)

Interrupted cochlear implant habilitation due to COVID-19 pandemic-ways and means to overcome this
por: Dham, Ruchima, et al.
Publicado: (2020)

Interferon Regulatory Factor (Irf)-1 and Irf-2 Regulate Interferon γ–Dependent Cyclooxygenase 2 Expression
por: Blanco, Jorge C. G., et al.
Publicado: (2000)

IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus
por: Manni, Michela, et al.
Publicado: (2015)

The macrophage IRF8/IRF1 regulome is required for protection against infections and is associated with chronic inflammation
por: Langlais, David, et al.
Publicado: (2016)

Beyond Sensation: Exploring the Molecular and Genetic Basis for Pain: An Interview with Stephen Waxman, MD, PhD 
por: DeNardo, Erin K.
Publicado: (2018)

TRIM14 expression is regulated by IRF‐1 and IRF‐2
por: Cui, Jingang, et al.
Publicado: (2019)

Oncogenic Kras-Mediated Cytokine CCL15 Regulates Pancreatic Cancer Cell Migration and Invasion through ROS
por: Messex, Justin K., et al.
Publicado: (2022)

Burden and Unmet Needs in Migraine Patients: Results from the OVERCOME (Spain) Study
por: Pascual, Julio, et al.
Publicado: (2023)

Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study
por: Pascual, Julio, et al.
Publicado: (2023)

Compensatory dendritic cell development mediated by BATF-IRF interactions
por: Tussiwand, Roxane, et al.
Publicado: (2012)

GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors
por: DeNardo, David G, et al.
Publicado: (2021)

Correction: Preventive treatment patterns and treatment satisfaction in migraine: results of the OVERCOME (EU) study
por: Pascual, Julio, et al.
Publicado: (2023)

cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
por: Bellovin, David, et al.
Publicado: (2015)

IRF3 and IRF7 mediate neovascularization via inflammatory cytokines
por: Simons, Karin H., et al.
Publicado: (2019)

Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication
por: Poat, Bret, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_khg1quagp426fop7jrshh1lh1e